BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND AMER1, RP11-403E24_2, 139285, FAM123B, ENSG00000184675, FLJ39827, WTX AND Clinical Outcome
439 results:

  • 1. Somatostatin receptor 2 (SSTR2) expression is associated with better clinical outcome and prognosis in rectal neuroendocrine tumors.
    Kim JY; Kim J; Kim YI; Yang DH; Yoo C; Park IJ; Ryoo BY; Ryu JS; Hong SM
    Sci Rep; 2024 Feb; 14(1):4047. PubMed ID: 38374188
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Impact of histological subtypes on clinical outcome of endocervical adenocarcinoma.
    Tian X; Liu P; Kang S; Cui Z; Sun L; Lang J; Chen C
    Eur J Surg Oncol; 2024 Apr; 50(4):107977. PubMed ID: 38373385
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. clinical features and outcomes of advanced HER2+ esophageal/GEJ cancer with brain metastasis.
    Liang K; Feliciano JL; Marrone KA; Murray JC; Hann CL; Anagnostou V; Tackett SA; Shin EJ; Hales RK; Voong KR; Battafarano RJ; Yang SC; Broderick SR; Ha JS; Forde PM; Brahmer JR; Lam VK
    ESMO Open; 2024 Jan; 9(1):102199. PubMed ID: 38071928
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Zhao S; Li Y; Xu J; Shen L
    Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Predictive factors and prognosis of upper gastrointestinal bleeding in gastric cancer: A large population-based study (UGIB-GC trial).
    Kiattiweerasak A; Bongkotvirawan P; Aumpan N; Yamaoka Y; Miftahussurur M; Vilaichone RK
    PLoS One; 2023; 18(9):e0291926. PubMed ID: 37729185
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comparing effectiveness and safety of paclitaxel plus raltitrexed
    Zhao X; Chen Z; Zhang X; Zhu X; Zhang W; Qiu L; Wang C; Huang M; Zhang Z; Li W; Yang L; Guo W
    Cancer Biol Med; 2023 Aug; 20(9):682-8. PubMed ID: 37653589
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A non-inferiority randomized phase III trial of standard immunotherapy by checkpoint inhibitors vs. reduced dose intensity in responding patients with metastatic cancer: the MOIO protocol study.
    Gravis G; Marino P; Olive D; Penault-LLorca F; Delord JP; Simon C; Lamrani-Ghaouti A; Sabatier R; Ciccolini J; Boher JM
    BMC Cancer; 2023 May; 23(1):393. PubMed ID: 37131154
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Effect of neoadjuvant chemotherapy combined with arterial chemoembolization on short-term clinical outcome of locally advanced gastric cancer.
    Yang J; Li J; Deng Q; Chen Z; He K; Chen Y; Fu Z
    BMC Cancer; 2023 Mar; 23(1):246. PubMed ID: 36918834
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Costs and clinical benefits of enhanced recovery after surgery (ERAS) in pancreaticoduodenectomy: an updated systematic review and meta-analysis.
    Noba L; Rodgers S; Doi L; Chandler C; Hariharan D; Yip V
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6639-6660. PubMed ID: 36629919
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Differential Expression of RSK4 Transcript Isoforms in cancer and Its clinical Relevance.
    Chen S; Seckl MJ; Lorentzen MPG; Pardo OE
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498899
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Combined high NEDD9 expression and E-cadherin loss correlate with poor clinical outcome in gastric cancer.
    Im S; Cho YK; Kang D; Shin GY; Jung ES; Song KY; Lee SH; Park JM
    J Gastroenterol Hepatol; 2022 Dec; 37(12):2255-2263. PubMed ID: 36203318
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Real-world data analysis of 3012 patients undergoing laparoscopic radical gastrectomy in a single center over the past 12 years].
    Wang LJ; Li Z; Wang S; Liu HD; Li QY; Li BW; Xu JH; Ge H; Wang WZ; Li FY; He ZY; Zhang DC; Xu H; Yang L; Xu ZK
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Aug; 25(8):716-725. PubMed ID: 35970806
    [No Abstract]    [Full Text] [Related]  

  • 13. gastric defect closure after endoscopic full-thickness resection: the closing while dissecting technique.
    Sun H; Cao T; Zhang F; Tao K; Xu H
    Surg Endosc; 2023 Jan; 37(1):234-240. PubMed ID: 35920910
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. GEP-NET radiomics: a systematic review and radiomics quality score assessment.
    Staal FCR; Aalbersberg EA; van der Velden D; Wilthagen EA; Tesselaar MET; Beets-Tan RGH; Maas M
    Eur Radiol; 2022 Oct; 32(10):7278-7294. PubMed ID: 35882634
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol.
    Huemer F; Hecht S; Scharinger B; Schlintl V; Rinnerthaler G; Schlick K; Heregger R; Melchardt T; Wimmer A; Mühlbacher I; Koch OO; Neureiter D; Klieser E; Seyedinia S; Beheshti M; Greil R; Weiss L
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3051-3064. PubMed ID: 35864270
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Efficacy of the Oral Administration of Maltodextrin Fructose Before Major Abdominal Surgery: A Prospective, Multicenter clinical Study.
    Qin H; Ji J; Miao Y; Liu T; Zhao D; Jia Z; Jiang J; Liu J; Li Q; Ji X; Fu W; Lou D; Xia W; Li N
    World J Surg; 2022 Sep; 46(9):2132-2140. PubMed ID: 35718790
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Identification of specific role of SNX family in gastric cancer prognosis evaluation.
    Hu B; Yin G; Sun X
    Sci Rep; 2022 Jun; 12(1):10231. PubMed ID: 35715463
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Essential Roles of TDO2 in gastric cancer: TDO2 Is Associated with cancer Progression, Patient Survival, PD-L1 Expression, and cancer Stem Cells.
    Pham QT; Taniyama D; Akabane S; Takashima T; Maruyama R; Sekino Y; Sentani K; Yasui W; Oue N
    Pathobiology; 2023; 90(1):44-55. PubMed ID: 35679834
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prognostic significance of the immune checkpoint HLA-G/ILT-4 in the survival of patients with gastric cancer.
    Chen QY; Zhou WJ; Zhang JG; Zhang X; Han QY; Lin A; Yan WH
    Int Immunopharmacol; 2022 Aug; 109():108798. PubMed ID: 35569305
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Hypoxia inducible lncRNA-CBSLR modulates ferroptosis through m6A-YTHDF2-dependent modulation of CBS in gastric cancer.
    Yang H; Hu Y; Weng M; Liu X; Wan P; Hu Y; Ma M; Zhang Y; Xia H; Lv K
    J Adv Res; 2022 Mar; 37():91-106. PubMed ID: 35499052
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 22.